StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.52+0.19 (+2.59%)

Close on Nov 18, 2026Market cap $102.61MP/E –Yield 0.00%

Immunic market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immunic's market cap was $110.79M on Nov 11, 2026, against $70.23M a year earlier. Over the last 5 years it ranged from $40.96M to $309.48M, with a median of $98.26M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$110.79M+110.4%
2025Dec 31, 2025$52.65M-41.6%
2024Dec 31, 2024$90.08M+34.7%
2023Dec 29, 2023$66.89M+56.3%
2022Dec 30, 2022$42.79M-83.0%
2021Dec 31, 2021$251.21M-20.7%
2020Dec 31, 2020$316.78M+224.3%
2019Dec 31, 2019$97.69M+1446.9%
2018Dec 31, 2018$6.31M-96.9%
2017Dec 29, 2017$200.91M+80.7%
2016Dec 30, 2016$111.18M-50.0%
2015Dec 31, 2015$222.52M-48.8%
2014Dec 31, 2014$434.60M–

More Immunic figures

See a number that looks wrong?